A Phase I Trial of a Single Intravitreal Injection of REDD14NP to Patients With CNV Secondary to Wet AMD

This study is currently recruiting participants.

Study NCT00455481 Information provided by Quark Pharmaceuticals

First Received: March 30, 2007 Last Updated: October 30, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	No date given